The Federal Trade Commission (FTC), charged with protecting the American consumer, on January 15, 2025, issued a special ...

FTC slams pharmacy benefit managers in first report from ongoing investigation On Tuesday, regulators updated the public on their almost three-year-old inquiry into PBMs’ anticompetitive ...

“The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of ...

Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent pharmacies ...

In a new lawsuit filed Friday, the Federal Trade Commission said it's going after one link in the chain: pharmacy benefit managers (PBMs). The FTC brought action against the top PBMs — CVS ...

FTC sues major pharmacy benefit managers over insulin prices The agency brought action against Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating ...

Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says Investigation finds firms, which are supposed to control spending, have overcharged for cancer drugs and taken other steps raising costs By ...

Why the FTC claims Pharmacy Benefit Managers are driving up drug prices : The Indicator from Planet Money A group of obscure yet powerful players in the prescription drug industry are under the ...

The Federal Trade Commission (FTC) is expanding its probe into pharmacy benefit managers by issuing compulsory orders to two group purchasing organizations that negotiate rebates on behalf of PBMs.

40% of generic drugs are made by one manufacturer 01:04. The Federal Trade Commission is starting an inquiry into the operations of pharmacy benefit managers who control access to prescription ...

The Federal Trade Commission declined to investigate how the business practices of pharmacy benefit managers affect drug prices. In a split 2–2 vote, the FTC failed to get the majority needed on ...

The Federal Trade Commission on Tuesday released a long-awaited report slamming the pharmacy benefit manager industry for manipulating the drug supply chain to profit at the expense of patients ...